Congress should end this abysmal ObamaCare failure
The Center for Medicare and Medicaid Innovation (CMMI) has failed to meet its objectives of reducing costs and improving care, and the Abolish CMMI Act has been introduced to stop wasting tax dollars…
The Center for Medicare and Medicaid Innovation (CMMI) has failed to meet its objectives of reducing costs and improving care, and the Abolish CMMI Ac
Read Full Story at The Hill →Why This Matters
The failure of CMMI represents more than just bureaucratic inefficiency—it underscores a fundamental mismatch between federal healthcare policy and the realities of a fragmented, costly medical system. For taxpayers, this misalignment means billions in wasted funding, while for patients, it erodes trust in institutions tasked with their care. The debate over CMMI’s future could reshape the balance between government intervention and market-driven solutions in healthcare.
Background Context
Created under the Affordable Care Act, CMMI was designed as a laboratory for testing innovative payment models to curb spending and elevate care quality. Yet despite a decade of experimentation—including accountable care organizations and bundled payments—many projects have fallen short of their targets, with critics arguing the agency’s top-down approach stifles local adaptability. Meanwhile, insurers and providers have grown skeptical, fearing that CMMI’s mandates could destabilize existing systems without delivering promised results.
What Happens Next
The Abolish CMMI Act’s introduction signals a potential turning point, but its path through Congress remains uncertain amid partisan divides over healthcare reform. If passed, the legislation could force a reckoning on how future innovations are tested, possibly shifting authority to states or private entities. Alternatively, a compromise might emerge, such as narrowing CMMI’s scope or imposing stricter accountability measures to salvage its credibility.
Bigger Picture
This controversy reflects a broader tension in American healthcare: the push for systemic reform versus the resistance to top-down solutions. As CMMI’s struggles mount, parallels emerge in other federal initiatives, from drug pricing reforms to Medicare Advantage overhauls, where ambitious goals clash with operational realities. The outcome here may set a precedent for whether Washington can effectively pilot large-scale healthcare changes—or if incremental, market-based adjustments will prevail.
